The Efficacy and Safety of a Selective Estrogen Receptor Beta Agonist (LY500307) for Negative Symptoms and Cognitive Impairment Associated With Schizophrenia
Clinical trial NCT01874756 · TERMINATED
Trial details
- NCT number
- NCT01874756
- Sponsor
- Indiana University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2017-12-01
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.